Humoral and cellular immunogenicity of homologous and heterologous booster vaccination in Ad26.COV2.S-primed individuals: Comparison by breakthrough infection

BACKGROUND: Whether or not a single-dose Ad26.COV2.S prime and boost vaccination induces sufficient immunity is unclear. Concerns about the increased risk of breakthrough infections in the Ad26.COV2.S-primed population have also been raised. METHODS: A prospective cohort study was conducted. Partici...

Descripción completa

Detalles Bibliográficos
Autores principales: Hyun, Hakjun, Jang, A-Yeung, Park, Heedo, Heo, Jung Yeon, Seo, Yu Bin, Nham, Eliel, Yoon, Jin Gu, Seong, Hye, Noh, Ji Yun, Cheong, Hee Jin, Kim, Woo Joo, Yoon, Soo-Young, Seok, Jong Hyeon, Kim, Jineui, Park, Man-Seong, Song, Joon Young
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10027912/
https://www.ncbi.nlm.nih.gov/pubmed/36960070
http://dx.doi.org/10.3389/fimmu.2023.1131229

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10027912/
https://www.ncbi.nlm.nih.gov/pubmed/36960070
http://dx.doi.org/10.3389/fimmu.2023.1131229

Ejemplares similares